Journal
CLINICS IN PLASTIC SURGERY
Volume 37, Issue 1, Pages 127-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cps.2009.07.008
Keywords
Melanoma; Chemotherapy; Biochemotherapy; Interferon; Interleukin-2
Categories
Ask authors/readers for more resources
This article provides a review of the current medical management of patients with high-risk and metastatic cutaneous melanoma, including a review of the use of adjuvant interferon therapy and a discussion of adjuvant treatments under evaluation. The use of standard chemotherapeutic agents for metastatic disease is discussed, with an emphasis on developmental therapeutics using targeted agents. This discussion includes a review of the immune therapy for metastatic melanoma, including newer immunomodulatory agents and cellular therapeutics that are expected to significantly impact the care of these patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available